Quantitation of clonotypic B-cells in multiple myeloma (MM) patients prior to autologous peripheral blood stem cell transplantation (APBSCT) correlates with outcome of MM patients after APBSCT.

被引：0
|
作者：
Chang, CC [1 ]
Dimitrov, R [1 ]
Novoa-Takara, L [1 ]
Woodliff, J [1 ]
Logan, B [1 ]
Vesole, DH [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1681
引用
收藏
页码：434A / 435A
页数：2
相关论文
共 50 条
  • [21] Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation
    Guikema, JEJ
    Vellenga, E
    Veeneman, JM
    Hovenga, S
    Bakkus, MHC
    Klip, H
    Bos, NA
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) : 748 - 754
  • [22] Allogeneic peripheral blood stem cell (PBSC) transplantation in multiple myeloma (MM).
    Majolino, I
    Tarella, C
    Scime, R
    Santoro, A
    Corradini, P
    Cavallaro, AM
    Palumbo, A
    Indovina, A
    Caracciolo, D
    Boccadoro, M
    Marceno, R
    Pileri, A
    BLOOD, 1997, 90 (10) : 4502 - 4502
  • [23] The clinical research of improved effect for immune reconstitution of ginsenoside Rg3 for patients after autologous peripheral blood stem cell transplantation (APBSCT)
    Wang, H.
    Zhang, H.
    Yao, Z.
    Hao, X.
    ANNALS OF ONCOLOGY, 2008, 19 : 241 - 241
  • [24] Autologous peripheral blood stem cell transplantation (APBSCT) with CD34+ selected cells in patients with myeloma and low-grade non-Hodgkin lymphoma.
    Cudillo, L
    Picardi, A
    Dentamaro, T
    Rainaldi, A
    Cantonetti, M
    Perrotti, A
    Adorno, G
    Caravita, T
    Buccisano, F
    Tribalto, M
    Amadori, S
    BONE MARROW TRANSPLANTATION, 1998, 21 : S178 - S178
  • [25] PATIENTS WITH MULTIPLE MYELOMA (MM) IN LONG TERM COMPLETE REMISSION (LTCR) AFTER AUTOLOGOUS TRANSPLANT (APBSCT) EXPRESS A DISTINCTIVE INMUNE PROFILE WITH POTENTIAL PROGNOSIS VALUE
    Arteche-Lopez, A.
    Amor, A. Alegre
    Kreutzmann, A.
    Aguado, B.
    Martinez, M. Espino
    Villar, L. M.
    Sanz, P.
    Arriero, A.
    Munoz-Calleja, C.
    HAEMATOLOGICA, 2017, 102 : 535 - 535
  • [26] Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) for patients with Multiple Myeloma (MM) - single centre experience
    Cheung, B
    Ackers, C
    Powles, R
    Rigg, A
    Lal, R
    Treleaven, J
    Saso, R
    Sirohi, B
    Kulkarni, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S253 - S253
  • [27] Busulfan plus melfalan in autologous blood stem cell transplantation for multiple myeloma (MM).
    Massumoto, C
    Mizukami, S
    Campos, MF
    Silva, L
    Graziani, S
    BLOOD, 1998, 92 (10) : 324B - 324B
  • [28] A comparison of 3 staging systems for the outcome following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM).
    Sohn, HJ
    Kim, K
    Lee, JH
    Bang, SM
    Kim, DH
    Lee, JJ
    Suh, C
    BLOOD, 2005, 106 (11) : 457B - 458B
  • [29] B-Cell Profile in Bone Marrow and Peripheral Blood of Multiple Myeloma Patients After Autologous Stem Cell Transplantation
    Barbosa, Eduarda
    Pontes, Roberia
    Sanoja-Flores, Luzalba
    Montero, Juan
    Salgado, Anna Beatriz
    Puig, Noemi
    Pessoa de Magalhaes Filho, Roberto Jose
    Mateos Manteca, Maria-Victoria
    Van Dongen, Jacques
    Maiolino, Angelo
    Sobral, Elaine
    Orfao, Alberto
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S151 - S151
  • [30] Impact of prior lenalidomide treatment on peripheral blood stem cell (PBSC) mobilization in untreated multiple myeloma (MM) patients
    Mazumder, Amitabha
    Kaufman, Jonathan
    Lonial, Sagar
    Jagannath, Sundar
    Vesole, David
    BLOOD, 2007, 110 (11) : 1057A - 1057A
12345